Exciting Moments from Japan IT Week 2025 🇯🇵

We were thrilled to showcase AICU’s innovative health solutions—including our Gait Scanner and Fecal Scanner—at Japan IT Week! As Japan faces the unique challenges of a rapidly aging society, early detection of neurodegenerative diseases has never been more important. It was incredibly rewarding to see such strong interest from Japanese clinicians and partners in our AI-powered gait analysis technology.

A special thank-you to everyone who visited our booth and shared valuable insights! We’re also excited to announce that we’ll be holding a live demo session at the National Cancer Center Japan in June—stay tuned for details.

📖 Further Reading: Gait-Based Early Detection in Japan

Are you interested on these subjects? Take a look at this sources 👀

• Dual decline in subjective gait speed and domain-specific cognition is associated with higher risk of incident dementia in older Japanese adults: A 15-year age-specific cohort study Archives of Gerontology and Geriatrics (Feb 2024) This landmark study tracked over 480 Japanese adults (aged 65 at baseline) for more than a decade. It found that individuals who experienced simultaneous declines in both gait speed and specific cognitive tests were far more likely to develop dementia by age 85—especially men. A clear call to integrate simple gait screening into early‐ dementia checks.
• Artificial intelligence–enabled gait analysis for early detection of cognitive impairment in community-dwelling older adults Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2024)In this Japanese clinical trial, pelvis/ankle sensors collected walking data from more than 12,000 strides. A deep-learning model flagged mild cognitive impairment with an AUC of 0.833. Their work highlights how smartphone-enabled AI gait features can screen for early cognitive decline right in people’s homes.
• Gait speed reflects cognitive impairment in early Alzheimer’s disease Alzheimer’s & Dementia (2024)Just published, this paper shows that simple gait-speed tests correlate strongly with early Alzheimer’s biomarkers—long before memory tests turn positive. Researchers propose that routine gait monitoring (already common in Japan’s senior health programs) could serve as an accessible, low-cost screening tool for cognitive decline.